id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0655-0022,FDA,FDA-2011-N-0655,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2017-11-07T16:01:20Z,2017-24189,0,0,0900006482c549c0
FDA-2011-N-0655-0021,FDA,FDA-2011-N-0655,AGDUFA III Summary of the Proposed Changes to the FD&C Act and Proposed Bill Language,Other,Letter(s),2017-11-01T04:00:00Z,2017,11,2017-11-01T04:00:00Z,,2017-11-01T16:50:29Z,,0,0,0900006482c3127a
FDA-2011-N-0655-0020,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act Reauthorization Performance Goals and Procedures for FY's 2019 thru 2023,Other,Letter(s),2017-11-01T04:00:00Z,2017,11,2017-11-01T04:00:00Z,,2017-11-01T16:44:29Z,,0,0,0900006482c30dfd
FDA-2011-N-0655-0019,FDA,FDA-2011-N-0655,"Animal Generic Drug User Fee Act; Recommendations; Request for
Comments; Extension of Comment Period",Notice,Extension of Comment Period,2017-10-25T04:00:00Z,2017,10,2017-10-25T04:00:00Z,2017-11-25T04:59:59Z,2017-11-25T02:06:06Z,2017-23173,0,0,0900006482c023ef
FDA-2011-N-0655-0018,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2017-10-05T04:00:00Z,2017,10,2017-10-05T04:00:00Z,2017-11-18T04:59:59Z,2017-10-05T14:09:06Z,2017-21438,0,0,0900006482b9f079
FDA-2011-N-0655-0017,FDA,FDA-2011-N-0655,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Animal Generic
Drug User Fee Act Cover Sheet",Notice,30 Day Proposed Information Collection,2017-06-15T04:00:00Z,2017,6,2017-06-15T04:00:00Z,2017-07-18T03:59:59Z,2017-06-15T13:58:54Z,2017-12432,0,0,09000064826dbc30